Atai Life Sciences Return On Tangible Equity 2020-2024 | ATAI

Atai Life Sciences return on tangible equity from 2020 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Atai Life Sciences Return On Tangible Equity 2020-2024 | ATAI

Atai Life Sciences return on tangible equity from 2020 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.4B
Quest Diagnostics (DGX)$17.8B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$7B
RadNet (RDNT)$5.4B
Option Care Health (OPCH)$3.8B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.8B
Addus HomeCare (ADUS)$2.3B
Astrana Health (ASTH)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Daxor (DXR)$46M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$11M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M